{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Impact of Tumor-Infiltrating B Cells in Lung Adenocarcinoma ((Non-Physician Credit))

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

The certificate for this activity is for NON-PHYSICIANS.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify a type of cancer in which tumor-infiltrating B cells affect patient responses to immunotherapy.
  2. Summarize results from research revealing the spatial landscape of tumor-infiltrating B cells and plasma cells in early-stage lung adenocarcinoma (LUAD).

Disclosures

The author(s), faculty, staff, and planners have no relevant financial relationships with any ineligible organizations regarding this educational activity.

Price: $10.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Other Health Professional
Test Code: OTN0123
Published: January 2023
Expires: 12/31/2024
Sources: Oncology Times
Required Passing Score: 4/5 (80%)
Authors: Lindsey Nolen
Categories: Hematology , Oncology
Specialties: Hematology, Oncology
Topics: Lung Adenocarcinoma